Expression of monocyte chemoattractant protein-1 in peritoneal endometriotic cells

other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-10

Peritoneal endometriotic cells and stromal macrophages express monocyte chemoattractant protein-1 (MCP-1), which is elevated in the peritoneal fluid of women with endometriosis, particularly in early stages.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text

The paper investigated whether monocyte chemoattractant protein-1 (MCP-1) is elevated in peritoneal fluid and expressed within endometriotic lesions, measuring MCP-1 by ELISA in women with and without endometriosis and assessing MCP-1 protein and mRNA in pelvic peritoneal lesions using immunohistochemistry and nonradioactive in situ hybridization. MCP-1 concentrations in peritoneal fluid were significantly higher in patients with endometriosis (P<0.05), with the largest elevation observed in stage I, while no statistically significant differences were detected among later stages I–IV. MCP-1-positive cells were localized to the glandular epithelium of endometriotic lesions and stromal macrophages, and these cells showed MCP-1 mRNA expression by in situ hybridization. This paper is centrally about endometriosis — specifically MCP-1 expression in peritoneal fluid and peritoneal endometriotic cells/lesions, with a finding of heightened levels in early-stage disease.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

It is well known that the number of peritoneal macrophages is increased in patients with pelvic endometriosis. We measured the concentration of monocyte chemoattractant protein-1 (MCP-1) using an enzyme-linked immunosorbent assay (ELISA) in the peritoneal fluid of women with and without endometriosis. The expression of MCP-1 in pelvic endometriotic lesions obtained from the peritoneum was also examined using immunohistochemistry and nonradioactive in situ hybridization. The mean concentration of MCP-1 in the peritoneal fluid was significantly higher in the patients with endometriosis (P<0.05). The most significant elevation, compared with non-endometriosis patients, was found in stage I of the disease (P<0.05). However, no statistically significant difference was found among endometriosis stages I, II, III, and IV. Immunohistochemical staining revealed that MCP-1-positive cells were localized in the glandular epithelium of the endometriotic lesions and in the stromal macrophages distributed in those lesions, but normal peritoneal cells were negative. The in situ hybridization method demonstrated expression of MCP-1 mRNA on the endometriotic glandular epithelium and stromal macrophages. These findings suggest that MCP-1 may be involved in the histogenesis and early development of peritoneal endometriosis.
Full text 1,795 characters · extracted from oa-doi-fallback · click to expand
Abstract. It is well known that the number of peritoneal macrophages is increased in patients with pelvic endometriosis. We measured the concentration of monocyte chemoattractant protein-1 (MCP-1) using an enzyme-linked immunosorbent assay (ELISA) in the peritoneal fluid of women with and without endometriosis. The expression of MCP-1 in pelvic endometriotic lesions obtained from the peritoneum was also examined using immunohistochemistry and nonradioactive in situ hybridization. The mean concentration of MCP-1 in the peritoneal fluid was significantly higher in the patients with endometriosis (P<0.05). The most significant elevation, compared with non-endometriosis patients, was found in stage I of the disease (P<0.05). However, no statistically significant difference was found among endometriosis stages I, II, III, and IV. Immunohistochemical staining revealed that MCP-1-positive cells were localized in the glandular epithelium of the endometriotic lesions and in the stromal macrophages distributed in those lesions, but normal peritoneal cells were negative. The in situ hybridization method demonstrated expression of MCP-1 mRNA on the endometriotic glandular epithelium and stromal macrophages. These findings suggest that MCP-1 may be involved in the histogenesis and early development of peritoneal endometriosis. Similar content being viewed by others Author information Authors and Affiliations Additional information Electronic Publication Rights and permissions About this article Cite this article Yih, S., Katabuchi, H., Araki, M. et al. Expression of monocyte chemoattractant protein-1 in peritoneal endometriotic cells. Virchows Arch 438, 70–77 (2001). https://doi.org/10.1007/s004280000263 Received: Accepted: Issue date: DOI: https://doi.org/10.1007/s004280000263

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Ascitic Fluid Chemokine CCL2 Chemokine CCL2 Endometriosis Gene Expression Macrophages, Peritoneal Ascitic Fluid Chemokine CCL2 Endometriosis Epithelium Epithelium Female Humans Immunoenzyme Techniques Immunohistochemistry In Situ Hybridization Macrophages, Peritoneal RNA, Messenger RNA, Messenger Stromal Cells

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
pubmed
last seen: 2026-05-13T22:13:30.513821+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine